Antineoplastics and immunomodulators 2026-II Cytostatikums content of the active substance abemaciklib
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Antineoplastics and immunomodulators 2026-II Cytostatikums content of the active substance abemaciklib
P.o. forma s obsahem 100 mg abemaciklibu v jednotce formy, předpokládaný roční objem 26 600 jednotek formy (dávek); p.o. forma s obsahem 150 mg abemaciklibu v jednotce formy, předpokládaný roční objem39,200 units of form (batch); ATC L01EF03
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals